statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Research analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a "sell...

Trevena (NASDAQ:TRVN) Coverage Initiated by Analysts at StockNews.com

Trevena (NASDAQ:TRVN - Get Free Report)s stock had its "buy" rating reissued by stock analysts at HC Wainwright in a research note issued on Tuesday, Benzinga reports. They presently have a...

HC Wainwright Reiterates "Buy" Rating for Trevena (NASDAQ:TRVN)

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Trevena reports Q4 EPS ($1.06) vs (73c) last year

TRV045, novel S1P receptor modulator for chronic pain and epilepsy, advances toward important milestones in both non-clinical and clinical studies Company announces reduction of OLINVYK commercial...

Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update

Trevena Inc (TRVN) has issued an announcement. Discover the latest insights into our business strategies and performance with the newly updated cor...

Trevena Inc Unveils Updated Corporate Strategy Presentation

Analysts at StockNews.com initiated coverage on shares of Trevena (NASDAQ:TRVN - Get Free Report) in a research report issued on Friday. The firm set a "sell" rating on the biopharmaceutical...

Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Trevena (NASDAQ:TRVN  Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the...

Analysts at StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN  Get Free Report) in a note issued to investors on Sunday. The brokerage set a sell rating on the...

StockNews.com Initiates Coverage on Trevena (NASDAQ:TRVN)

Trevena (NASDAQ:TRVN  Get Free Report) and JanOne (NASDAQ:JAN  Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies...

Critical Contrast: Trevena (NASDAQ:TRVN) & JanOne (NASDAQ:JAN)

StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN  Free Report) in a report released on Saturday. The brokerage issued a sell rating on the biopharmaceutical companys...

Trevena (NASDAQ:TRVN) Now Covered by Analysts at StockNews.com

Trevena, Inc. is a biopharmaceutical company, which focuses on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders. Its product candidates include Oliceridine injection, TRV250, TRV734, and TRV045. The company was founded by Maxine Gowen, Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin, and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.

Volume	22,209.00
52-Wk High	$3.28
52-Wk Low	$0.3001

TRVN Trevena Inc

About

Feed

News

Sentiment

Earnings

Fundamentals